Coenzyme Q10 + NADH

Coenzyme Q10 + NADH has been studied in 1 paper since 2014: 1 trial in people. The newest paper, Dec 18, 2014: “Does oral coenzyme Q10 plus NADH supplementation improve fatigue and biochemical parameters in chronic fatigue syndrome?”.

Intervention

1 paper studies it1 more mentions it3 findingsUpdated

PubChemPubChemChEBIChEBI

See all 2 papers on coenzyme Q10 + NADH

At a glance

The findings reach people, from one lab or study. 1 lab in 1 country; 2 trials, none about aging.

“A significant improvement of fatigue showing a reduction in fatigue impact scale total score (p<0.05) was reported in treated group versus placebo.”
Does oral coenzyme Q10 plus NADH supplementation improve fatigue and biochemical parameters in chronic fatigue syndrome?Antioxidants & redox signaling2014doi:10.1089/ars.2014.6181

None of its findings points the other way.

Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 1 lab in 1 country
  • 2 trials, none about aging
  • Funders: Fundació Institut de Recerca Hospital Universitari Vall d’Hebron and 1 more
  • 3 of 3 findings with company ties
  • 2 of 2 trials sponsored by its developers
  • Human trial1

Studies in people

1 study gave coenzyme Q10 + NADH to people and measured what changed.

What changedDesignPeopleSource

down: Decreases fatigue impact scale total scorep<0.05

up: Increases NAD/NADH ratiop<0.001

down: Decreases lipid peroxidesp<0.05

Randomized trial8 weeks73 peopleChronic fatigue syndromeAntioxidants & redox signaling, Dec 18, 2014

What did studies of coenzyme Q10 + NADH find?

3

Studies of coenzyme Q10 + NADH measured 3 outcomes: lipid peroxides, NAD/NADH ratio and fatigue impact scale total score.

Lipid peroxides

downin humans1

1 study
  1. Coenzyme Q10 + NADH decreases lipid peroxides in humans (chronic fatigue syndrome) (p<0.05).

    “lipoperoxides (p<0.05) were significantly lower in blood mononuclear cells of the treated group.”

    Human trialchronic fatigue syndromeoralblood mononuclear cellsCoQ10 (200 mg/day) plus NADH (20 mg/day)8 weeksn = 73

    Does oral coenzyme Q10 plus NADH supplementation improve fatigue and biochemical parameters in chronic fatigue syndrome?

    Antioxidants & redox signaling

More on Lipid peroxides

NAD/NADH ratio

upin humans1

1 study
  1. Coenzyme Q10 + NADH increases NAD/NADH ratio in humans (chronic fatigue syndrome) (p<0.001).

    “NAD+/NADH (p<0.001), CoQ10 (p<0.05), ATP (p<0.05), and citrate synthase (p<0.05) were significantly higher”

    Human trialchronic fatigue syndromeoralblood mononuclear cellsCoQ10 (200 mg/day) plus NADH (20 mg/day)8 weeksn = 73

    Does oral coenzyme Q10 plus NADH supplementation improve fatigue and biochemical parameters in chronic fatigue syndrome?

    Antioxidants & redox signaling

More on NAD/NADH ratio

Fatigue impact scale total score

downin humans1

1 study
  1. Coenzyme Q10 + NADH decreases fatigue impact scale total score in humans (chronic fatigue syndrome) (p<0.05).

    “A significant improvement of fatigue showing a reduction in fatigue impact scale total score (p<0.05) was reported in treated group versus placebo.”

    Human trialchronic fatigue syndromeoralCoQ10 (200 mg/day) plus NADH (20 mg/day)8 weeksn = 73

    Does oral coenzyme Q10 plus NADH supplementation improve fatigue and biochemical parameters in chronic fatigue syndrome?

    Antioxidants & redox signaling

More on Fatigue impact scale total score

Latest